CAS: 2066488-39-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (S)-C33 REF: IN-DA01ENINCAS: 2066488-39-7 | 98% | To inquire | Wed 11 Dec 24 |
 | PDE9-IN-(S)-C33 REF: 3D-RHD48839CAS: 2066488-39-7 | Min. 95% | To inquire | Wed 22 Jan 25 |
 | PDE9-IN-(S)-C33 REF: TM-T28352CAS: 2066488-39-7 | 98.75% | 51.00 €~536.00 € | Wed 12 Feb 25 |
Ref: IN-DA01ENIN
| 10mg | 170.00 € | ||
| 25mg | 241.00 € | ||
| 50mg | 543.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
PDE9-IN-(S)-C33
CAS:2066488-39-7
PDE9-IN-(S)-C33 is a phosphodiesterase inhibitor that is used in the treatment of heart diseases such …
Formula:
C18H20ClN5O
Purity:
Min. 95%
Molecular weight:
357.8 g/mol
Ref: 3D-RHD48839
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
PDE9-IN-(S)-C33
CAS:2066488-39-7
PDE9-IN-(S)-C33: potent PDE9 inhibitor with 11 nM IC50, for CNS diseases and diabetes study.
Formula:
C18H20ClN5O
Purity:
98.75%
Color and Shape:
Solid
Molecular weight:
357.84
Ref: TM-T28352
| 1mg | 60.00 € | ||
| 5mg | 109.00 € | ||
| 10mg | 155.00 € | ||
| 25mg | 243.00 € | ||
| 50mg | 360.00 € | ||
| 100mg | 536.00 € | ||
| 1mL*10mM (DMSO) | 123.00 € |
Estimated delivery in United States, on Wednesday 12 Feb 2025
